# Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy

> **NCT04135326** · EARLY_PHASE1 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Chemotherapy-Induced Peripheral Neuropathy
- Malignant Neoplasm

## Interventions

- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Transcranial Direct Current Stimulation

## Key facts

- **NCT ID:** NCT04135326
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10-10
- **Primary completion:** 2020-10-26
- **Final completion:** 2020-10-26
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Per PI termination request, no patients enrolled
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04135326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04135326, "Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04135326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
